Focused Ultrasound Foundation Highlights RebrAIn’s AI Innovations in Neurosurgery

We are excited to share that the Focused Ultrasound Foundation has featured RebrAIn for our pioneering use of artificial intelligence in brain targeting.

The article details how our supervised AI-driven platform, Optim MRI, enhances precision and effectiveness in neurosurgical procedures such as Deep Brain Stimulation (DBS). This innovative technology, developed by Professor Emmanuel Cuny and Dr. Nejib Zemzemi, aims to improve patient outcomes and expand treatment options.

Discover our groundbreaking work by reading the full article.

Our latest public updates

Rebrain x Worldwide Dystonia Research Center

May 28, 2026

Partnership aims to develop next-generation data-driven models for personalized deep brain stimulation (DBS) targeting, expanding clinical applications from Parkinson’s disease and essential tremor to dystonia and severe pediatric dystonia with global scalability...

Rebrain unveils its identity: a strong vision for the future of assisted neurosurgery

May 21, 2026

At Rebrain, innovation has never been an end in itself. It has always been a means to improve the precision of neurosurgical procedures and to have a concrete impact on patients’ lives. Today, we are reaching a new stage of our development with the official launch of...

RebrAin 2025/2026: Expanding Reach, Driving Innovation

Jan 5, 2026

Transatlantic expansion RebrAIn’s focus for 2026 is expanding our reach to major neurosurgery reference centers in the US and Europe. Today, our top partner centers by volume are Duke University, University of Virginia (UVA), Pamplona and UCLA. These collaborations...

« Older Entries